ICD-10 Code F90.9: ADHD Unspecified Type – Billing & Documentation

Key Takeaways

F90.9 is the billable ICD-10-CM code for Attention-Deficit Hyperactivity Disorder, unspecified type – used when ADHD is confirmed but the dominant symptom presentation cannot be determined

Use F90.9 when DSM-5 criteria are met but presentation is genuinely unclear – not as a default shortcut instead of F90.0, F90.1, or F90.2

Overusing F90.9 without clinical justification can trigger payer documentation requests and slow prior authorization for stimulant medications

Pabau’s claims management software helps ADHD clinics document F90.9 accurately and reduce claim errors

Coding ADHD correctly is harder than it looks. Many clinicians default to F90.9 out of habit or time pressure, not because it genuinely reflects the patient’s presentation. That habit creates problems at billing time: payers expect specificity, and CMS ICD-10-CM coding guidelines require the most specific code available when the clinical evidence supports it.

ICD-10 code F90.9 has a legitimate role in clinical practice. This guide covers exactly when it applies, how it differs from the more specific F90.x subtypes, what documentation payers expect, and which CPT codes are commonly submitted alongside it. Whether you treat pediatric patients or adults newly diagnosed with ADHD, understanding this code protects your claims and your patients’ access to care.

ICD-10 Code F90.9: Definition and Clinical Description

ICD-10 code F90.9 designates Attention-Deficit Hyperactivity Disorder (ADHD), unspecified type. It is a billable, specific ICD-10-CM code confirmed in the FY2026 tabular list, making it valid for insurance reimbursement when documentation supports the diagnosis. The code sits within Chapter 5 (Mental, Behavioral and Neurodevelopmental Disorders, F01-F99), under the F90-F98 block covering behavioral and emotional disorders with onset typically occurring in childhood and adolescence.

Clinically, F90.9 maps to what older documentation often called “ADD, NOS” or “hyperkinetic syndrome, unspecified.” Under DSM-5 criteria, the diagnosis requires: six or more symptoms (five for adults 17+) of inattention and/or hyperactivity-impulsivity, present for at least six months, appearing before age 12, causing impairment in two or more settings. F90.9 applies when those criteria are met but the dominant presentation cannot yet be determined. ADHD clinic management workflows that capture structured symptom assessments at intake make subtype classification far easier.

According to the WHO ICD-10 browser, the F90 parent category encompasses all attention-deficit hyperactivity disorders, with F90.9 representing the least specific endpoint in that hierarchy. Per the official ICD-9 to ICD-10 General Equivalence Mappings (GEMs), F90.9 crosswalks to ICD-9-CM 314.9 (Unspecified hyperkinetic syndrome) as the primary approximate match, with 314.01 (Attention deficit disorder with hyperactivity) as a secondary approximate mapping for legacy claims that lacked subtype distinction. The transition to ICD-10-CM in 2015 created a cleaner subtype structure, and F90.9 fills the residual “unspecified” slot.

ADHD Subtype Codes: F90.0, F90.1, F90.2, and F90.8

Understanding when not to use F90.9 requires knowing the full F90.x hierarchy. Each subtype code corresponds to a distinct clinical presentation, and correct selection affects both reimbursement and medication prior authorization.

A mental health EMR that structures assessments around DSM-5 symptom domains makes this differentiation straightforward at the point of care. When clinicians document symptom counts per domain, the code selection often resolves itself without an additional coding step.

When to Use ICD-10 Code F90.9 vs. More Specific Subtypes

F90.9 is a legitimate code – but it carries a specific clinical meaning that coders and clinicians sometimes misapply. Three clinical scenarios justify its use; everything else should map to a more specific subtype.

Valid Use Case 1: Initial Evaluation Visit

At a first diagnostic encounter, collateral history from parents, teachers, or employers may not yet be available. The clinician has confirmed ADHD but cannot determine whether the presentation is predominantly inattentive, predominantly hyperactive-impulsive, or combined. F90.9 serves as a temporary placeholder pending a complete assessment. Once a Vanderbilt, Conners, or other validated rating scale confirms the dominant presentation, the code should be updated to F90.0, F90.1, or F90.2.

Valid Use Case 2: Presentation Does Not Clearly Fit One Subtype

Some patients – particularly adults diagnosed later in life – show a mixed pattern that falls just below the six-symptom threshold in both domains but still meets full diagnostic criteria when functional impairment is weighted. In these cases, the clinician may legitimately document that the presentation is unspecified and use F90.9. Note: this is distinct from combined type (F90.2), which requires six or more symptoms in both domains simultaneously.

Invalid Use Case: Convenience Coding

The most common coding error is selecting F90.9 because it is the first code that appears in a dropdown or because the documentation does not clearly describe symptom counts. Payers and Medicare Administrative Contractors expect the most specific code available. Using F90.9 when the chart clearly documents six or more inattention symptoms without a matching hyperactivity count is a documentation gap that triggers claim review. ICD-10-CM Official Guidelines for Coding and Reporting (FY2026) state that “the code that provides the most specific description of the condition” should be selected.

Documentation Requirements for F90.9

Clear documentation is what separates a clean F90.9 claim from one that attracts a medical necessity review. These are the elements payers and auditors look for when reviewing an F90.9 submission.

• DSM-5 diagnostic criteria met: Document the specific number of inattention and hyperactivity-impulsivity symptoms present, with at least one domain reaching the threshold (6+ for children, 5+ for adults).
• Age of onset: Confirm that symptoms were present before age 12, with supporting history from the patient or a reliable informant.
• Multi-setting impairment: Document functional impairment in at least two settings (school/work, home, social).
• Justification for “unspecified”: Explicitly note why a more specific subtype code was not selected – e.g., “Symptom presentation is currently mixed and does not clearly meet criteria for a single dominant subtype; reassessment with collateral rating scales scheduled.”
• Rule-out documentation: Briefly address that symptoms are not better explained by another condition (anxiety, learning disorder, mood disorder).
• Plan for reclassification: Note the intended follow-up and the expected timeline for assigning a more specific code.

Using a psychiatric evaluation template that prompts clinicians through each DSM-5 criterion reduces the risk of incomplete documentation. When the template is built into the clinical note, documentation gaps become visible before the encounter ends rather than at claims adjudication.

Psychiatry EMR software with structured note templates can generate the documentation logic automatically – prompting the provider to document symptom counts per domain, onset age, and multi-setting impairment in a consistent format across every ADHD encounter.

Billing Guidelines and Payer Considerations

F90.9 is billable to Medicare, Medicaid, and commercial payers. However, three payer-level factors affect how smoothly claims adjudicate.

Medicare and Medicaid Coverage

Medicare does cover psychiatric diagnoses including ADHD under Part B when medical necessity is documented. Some Medicare Administrative Contractors have issued Local Coverage Determinations (LCDs) that require additional documentation when an “unspecified” behavioral health code is submitted without a more specific alternative. Check your MAC’s current LCDs for mental health diagnoses before submitting F90.9 on Medicare claims, particularly for adult patients.

Prior Authorization for Stimulant Medications

Many commercial payers require prior authorization for stimulant medications (amphetamines, methylphenidate). Some payers accept F90.9 for initial authorization while others require a subtype code. Verify individual payer requirements before submitting. If a PA is denied citing lack of specificity, updating to a more specific F90.x code with revised documentation often resolves the issue faster than a peer-to-peer appeal. Payer requirements vary widely and change annually, so treat the prior authorization step as a verification point, not an assumption.

Audit Risk and Documentation Scrutiny

Claims submitted with F90.9 as the primary diagnosis receive closer documentation scrutiny than claims with specific subtype codes, particularly for adult patients where ADHD diagnosis rates have risen sharply in recent years. The “unspecified” designation signals to payer systems that subtype assessment may be incomplete. This is not grounds for automatic denial – but it does increase the probability of a documentation request. Claims management software that flags unspecified diagnosis codes before submission gives practices an opportunity to review documentation before the claim leaves the office.

One important note: a widely circulated claim that F90.9 increases audit probability by 280% references a source with no CMS or MAC backing. Treat that figure as unverified. What is confirmed is that unspecified codes attract more scrutiny than specific ones – sufficient reason to use F90.9 precisely and sparingly.

Reduce ADHD Claim Errors with Structured Documentation

Pabau's psychiatry EMR templates prompt clinicians to capture DSM-5 symptom counts, multi-setting impairment, and coding justification at every ADHD encounter – so claims go out clean the first time.

Book a demo

Related and Excluded Codes

Accurate ADHD coding requires knowing which conditions are classified separately and how comorbidities should be sequenced. The ICD-10-CM tabular list includes both inclusion terms and exclusion notes that affect F90.x code selection.

Type 2 Excludes (Excludes2)

The F90 block carries Type 2 Excludes notes for the following condition groups, meaning they are not classified within F90.x but CAN be coded concurrently with an F90.x code when both conditions are clinically present and documented:

• Anxiety and fear-related disorders (F40-F41): Anxiety disorders are not part of the F90 block, but they are commonly comorbid with ADHD. When the chart documents both an anxiety disorder and ADHD, code both. Sequence the primary reason for the encounter first and add the secondary diagnosis.
• Mood disorders (F30-F39): Bipolar and depressive disorders are coded outside F90.x but co-occur frequently with ADHD. When both conditions are independently established in the record, both diagnoses should be reported; clinical differentiation is still required so that overlapping symptoms are attributed to the correct disorder.
• Pervasive developmental disorders (F84.x): Autism Spectrum Disorder (F84.0) sits outside the F90 block, but DSM-5-TR explicitly permits a concurrent ADHD diagnosis when the inattention or hyperactivity meets criteria independently of the autism presentation. Code both when both are documented. Reviewing the autism spectrum disorder ICD-10 code guidance helps clarify when ASD features and ADHD symptomatology genuinely co-occur versus overlap.
• Schizophrenia (F20.-): Schizophrenia is also part of the F90 Excludes2 set. Where attention or activity disturbance is wholly accounted for by a primary psychotic disorder, F90.x is not assigned; where ADHD is independently documented in a patient who also has schizophrenia, both codes can be reported.

Comorbidity Coding and Sequencing

ADHD frequently presents alongside anxiety disorders (F41.x), specific learning disorders (F81.x), and Autism Spectrum Disorder (F84.0). When comorbidities are documented, code all confirmed conditions and sequence the primary reason for the visit first. For a follow-up visit focused on ADHD medication management, F90.9 (or the specific subtype) goes first; the anxiety diagnosis is listed as a secondary code. For a visit primarily addressing anxiety in a patient who also has ADHD, the anxiety code leads.

The CDC/NCHS ICD-10-CM web tool provides the official tabular list with all inclusion terms, exclusion notes, and sequencing guidance – always the authoritative source when payer disputes arise over code selection.

CPT Codes Commonly Billed with F90.9

F90.9 appears as a supporting diagnosis across multiple procedure code categories. The CPT codes below represent the most common pairings in ADHD clinical workflows.

CPT code 96127 is particularly relevant when administering validated rating scales like the Vanderbilt ADHD Rating Scale as part of the diagnostic workup. It reimburses separately from the E/M visit and requires documentation that a standardized instrument was administered and interpreted. Review the full set of ADHD screening CPT codes to ensure all billable services are captured at each encounter.

ICD-10 to ICD-9 Crosswalk for F90.9

Practices that maintain historical billing records, work with legacy systems, or coordinate with insurers that reference older claim data occasionally need the ICD-9-CM equivalent for F90.9. The crosswalk is not a 1:1 match because ICD-9-CM had fewer ADHD subtype distinctions.

• F90.9 (ICD-10-CM) crosswalks via the official ICD-9 to ICD-10 General Equivalence Mappings (GEMs) to 314.9 (Unspecified hyperkinetic syndrome) as the primary approximate match. 314.01 (Attention deficit disorder with hyperactivity) is a secondary approximate mapping for legacy claims where the original ICD-9 record did not distinguish a subtype.
• For reference, ICD-9-CM 314.00 was titled “Attention deficit disorder without mention of hyperactivity” and ICD-9-CM 314.01 was titled “Attention deficit disorder with hyperactivity”; these are the official ICD-9 wordings and should be used verbatim when annotating crosswalks. Because ICD-9-CM lacked a true “unspecified” ADHD code matching F90.9, the mapping is approximate and the original chart context determines which ICD-9 code best represents the legacy record.
• When working with Medicare claims data from before October 2015, use ResDAC’s ICD codes in Medicare files guidance to navigate the ICD-9 to ICD-10 transition accurately.

Expert Resources for ADHD Coding and Documentation

Expert Picks

Need a validated framework for ADHD assessment documentation? How to Score the Vanderbilt ADHD Rating Scale covers administration, scoring, and how to use results to support ICD-10 subtype selection.

Looking for structured psychiatric evaluation templates? Psychiatric Evaluation Template provides a step-by-step guide for comprehensive mental health assessments that capture DSM-5 criteria systematically.

Managing a specialist ADHD practice? ADHD clinic software built around neurodevelopmental workflows supports structured documentation, recall management, and claims accuracy.

Conclusion

ICD-10 code F90.9 belongs in a specific, narrow clinical context: confirmed ADHD where the dominant symptom presentation genuinely cannot yet be classified. Using it outside that context – as a default code or a billing shortcut – creates documentation gaps that slow claims and complicate medication authorizations.

Structured ADHD workflows remove most of the ambiguity. When DSM-5 symptom counts are documented at every encounter, subtype codes follow naturally from the clinical record. Pabau’s claims management software and psychiatry-focused documentation tools help ADHD clinics build that structure into each visit, reducing unspecified code usage and supporting cleaner claims from day one. To see how Pabau supports ADHD and mental health practices, book a demo.

Frequently Asked Questions